Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reported at the ASCO congress.
NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...
Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.
This article is part of Breast Cancer in Black Women, a destination in our Health Divide series. Black women have the lowest breast cancer survival rate, regardless of the stage at diagnosis. And ...
Shannon Strohl knew something was amiss. The Manheim Township woman suspected breast cancer when she felt a lump, but her primary care physician wasn’t quite sure. Strohl was only 29 and breast ...
A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes. A new randomized controlled trial out of ...
To enhance knowledge on breast cancer amongst Imo indigenes, the Ike Odoeme Foundation (TIOF) has launched an initiative to scale up awareness in Imo State. The Founder Ike Odoeme during the flag ...
Background Breast cancer incidence in women increases with age, while survival rates decrease. Studies interpret this result as meaning higher comorbidity, diagnosis at later stages of the disease ...
After undergoing biopsy for both lumps, the kindergarten teacher was diagnosed with breast cancer on Oct 4. She was informed on the same day that a mastectomy on her left breast was necessary. For ...
The potential of organic nanomaterials for the treatment of breast cancer is well-established and described in detail in several recent reviews. [20–23] In contrast to organic NPs, inorganic NPs ...